CytomX Therapeutics Inc
Closed
SectorHealthcare
3.38 4
Overview
Share price change
24h
Min
3.27
Max
3.42
Income | 8.3M -18M |
|---|---|
Sales | 9.6M 10M |
P/E Sector Avg | 22.5 50.958 |
EPS | -0.1 |
Profit margin | -177.89 |
Employees | 69 |
EBITDA | 9.5M -18M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +247.94% upside |
Next Earnings | 6 Aug 2026 |
|---|
Market Cap | -234M 676M |
|---|---|
Previous open | -0.62 |
Previous close | 3.38 |
News Sentiment
By Acuity
50%
50%
135 / 342 Healthcare
CytomX Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
CytomX Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 11.83 USD 247.94%
High 16 USD
Low 6 USD
Based on 6 Wall Street analysts offering 12 month price targets forCytomX Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$